Min You
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Advanced biosensing and bioanalysis techniques 9
- Fibroblast Growth Factor Research 6
- RNA Interference and Gene Delivery 5
-
- Cancer Research and Treatments 19
- Co-authors
- Gen‐Sheng Feng (2 shared papers)Dehua Yu (2 shared papers)Niramol Savaraj (25 shared papers)Medhi Wangpaichitr (24 shared papers)Kalina Hristova (7 shared papers)Edwin Li (7 shared papers)Lynn G. Feun (21 shared papers)Zhizhuang Joe Zhao (4 shared papers)
- Journals
- Cancer Research (8 papers)ACS Applied Materials & Interfaces (4 papers)Biochemistry (3 papers)Advanced Materials (3 papers)Journal of Natural Products (3 papers)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Min You
98 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 131
- Biotechnology 457
- Cancer Research 538
- Molecular Biology 2.6k
- Immunology 672
- Biochemistry 227
Countries citing papers authored by Min You
This map shows the geographic impact of Min You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min You more than expected).
Fields of papers citing papers by Min You
This network shows the impact of papers produced by Min You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min You. The network helps show where Min You may publish in the future.
Co-authors
The 25 scholars most cited alongside Min You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 397 | |
| 2 | 1999 | 313 | |
| 3 | Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. | 1997 | 225 |
| 4 | 1995 | 197 | |
| 5 | 2021 | 196 | |
| 6 | 2008 | 192 | |
| 7 | 2010 | 168 | |
| 8 | 1996 | 129 | |
| 9 | 2001 | 120 | |
| 10 | 1998 | 119 | |
| 11 | 2019 | 118 | |
| 12 | 2011 | 117 | |
| 13 | 2015 | 110 | |
| 14 | 1995 | 103 | |
| 15 | 2005 | 100 | |
| 16 | 2020 | 96 | |
| 17 | 2020 | 94 | |
| 18 | 2012 | 92 | |
| 19 | 2010 | 89 | |
| 20 | 2005 | 89 |
About Min You
Min You is a scholar working on Molecular Biology, Biotechnology, Biomedical Engineering, Genetics and Oncology, having authored 101 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Research and Treatments (19 papers), Virus-based gene therapy research (10 papers), Advanced biosensing and bioanalysis techniques (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Nanoplatforms for cancer theranostics (7 papers), Fibroblast Growth Factor Research (6 papers), RNA Interference and Gene Delivery (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Biotechnology (457 citations), Cancer Research (538 citations), Molecular Biology (2.6k citations), Immunology (672 citations) and Biochemistry (227 citations). Min You has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Gen‐Sheng Feng, Dehua Yu, Niramol Savaraj, Medhi Wangpaichitr, Kalina Hristova, Edwin Li, Lynn G. Feun, Zhizhuang Joe Zhao, Michinaga Matsumoto and Won Kyoo Cho. Their work appears in journals such as Cancer Research, ACS Applied Materials & Interfaces, Biochemistry, Advanced Materials and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.